Virbac SA (VRBCF PINK) stock market data APIs
$343.7895
0(0%)
as of December 24, 2025
Try our APIs with
free plan!
Virbac SA Financial Data Overview
Price chart is built with
Anychart
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.
Prev. Close
343.7895
Open
343.7895
High
343.7895
Low
343.7895
52 wk Range
320.9629-380.8165
Market Cap
2 899 M
P/E Ratio
17.0359
Shares Outstanding
8 378 K
Revenue
1 433 M
EPS
5.1056
Dividends (Yield)
0.0042
Beta
0.924
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Virbac SA data using free add-ons & libraries
Get Virbac SA Fundamental Data
Virbac SA Fundamental data includes:
- Net Revenue: 1 433 M
- EBITDA: 262 M
- Earnings Per Share: 20
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Virbac SA News
New
Virbac expands pet health portfolio with £100M acquisition of feline hyperthyroidism drug from Norbrook
Virbac (VRBCF [https://seekingalpha.com/symbol/VRBCF]) has bolstered its specialty pet health portfolio by acquiring a world-leading feline hyperthyroidism treatment from Norbrook, valued at approxima...
VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm
Virbac Acquisition provides Virbac with a leading specialty product, in a growing segment, to improve the quality of life for senior cats. We are delighted to announce the acquisition of an innova...
Virbac : Declaration of the number of shares and voting rights 11/2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the ...
How Analyst Optimism Is Changing the Growth Story for Virbac
Virbac's stock has recently seen a subtle, yet notable, change in its fair value estimate, increasing from €397.61 to €403.20. This revision comes as optimism grows over the company's operational ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
